期刊文献+

慢病毒感染方法构建稳定干涉PDRG1的HeLa细胞系 被引量:3

Construction of HeLa-PDRG1-knock Down Stable Cell Line by Lentivirus Infection
在线阅读 下载PDF
导出
摘要 PDRG1(p53 and DNA-damage regulated 1)是实验室通过文库筛选发现的参与NF-kB信号通路调控的一个新基因。已知PDRG1在多种肿瘤中高表达,并参与p53信号通路;同时该基因受UV以及基因毒性等刺激调控。但其在NF-κB信号通路中作用尚未见报道,为了深入研究PDRG1对NF-κB信号通路的调控机理,构建了稳定干涉PDRG1的HeLa细胞系。选择了基于慢病毒载体pLKO.1的感染体系,该慢病毒体系可以同时感染分裂期与非分裂期的细胞,将目的基因干涉序列稳定整合至靶细胞基因组中;再经过抗生素压力筛选后在短时间内获得稳定干涉目的基因表达的细胞株。设计合成PDRG1干涉序列并克隆至pLKO.1载体,转染病毒包装细胞293TN后收集慢病毒上清感染HeLa细胞系,进一步经过嘌呤霉素压力筛选成功获得稳定表达PDRG1干涉序列的细胞株。该稳定细胞株的建立为PDRG1的功能研究提供了必要的实验工具。 PDRG1(p53 and DNA-damage regulated1) is one of the proteins that play a role in the regulation of NF-κB signaling pathway and was found in our lab by library screening.There is evidence that the mRNA of PDRG1 was up-regulated by UV and genotoxicity while down-regulated by p53.PDRG1 was also over-expressed in relevant tumors,but its function in the NF-κB signaling pathway remains elusive.In order to make a further study of the function of PDRG1 in NF-κB signaling pathway,a stable cell line that can stably interfere the expression of PDRG1 is constructed with the HeLa cell by the integration of the PDRG1 inference sequence into the target cell through the lentivirus vector pLKO.1 and then the antibiotic screening to get the Anti-puro Positive cells.By combining the lentivirus infection and antibiotic screening,the efficiency of selection is markedly increased.This stable cell line will serve as a necessary element in the further study of PDRG1.
出处 《科学技术与工程》 北大核心 2013年第22期6385-6388,共4页 Science Technology and Engineering
关键词 PDRG1 慢病毒感染 抗生素筛选 稳定敲低细胞系 PDRG1 lentivirus infection antibiotic screening knock down-stable cell line
  • 相关文献

参考文献10

二级参考文献46

  • 1冯燕国,张贺龙,冯英明,胡玲,康艳霞,阮禹松.肺癌骨转移相关分子的比较蛋白质组学研究[J].现代肿瘤医学,2008,16(11):1854-1857. 被引量:3
  • 2谭书岩,谭树良,张爱东,谭绪成,谭绪富,宋延平,谭树萍,谭廷波.芬兰原种北极狐改良提高地产狐的效果评定[J].经济动物学报,2007,11(2):80-82. 被引量:3
  • 3高雅琴,常玉兰,梁丽娜,牛春娥,郭天芬,王宏博.我国蓝狐皮改良效果的分析研究[J].黑龙江畜牧兽医,2007(6):94-95. 被引量:2
  • 4Wong LF, Goodhead L, Prat C, et al. Lentivirus-mediated gene transfer to the central nervous system: therapeutic and research applications [ J ]. Hum Gene Ther,2006,17 ( 1 ) : 1.
  • 5Jakobsson J, Lundberg C. Lentiviral vectors for use in the central nervous system [ J ]. Mol Ther,2006,13 ( 3 ) :484.
  • 6Xu K, Ma H, McCown TJ, et al. Generation of a stable cell lineproducing high-titer self-inactivating lentiviral vectors[J]. Mol Ther,2001,3(1):97.
  • 7Azzouz M, Kingsman SM, Mazarakis ND. Lentiviral vectors for treating and modeling human CNS disorders[ J ]. J Gene Med, 2004,6(9) :951.
  • 8Vercammen L, Van der Perren A, Vaudano E, et al. Parkin protects against neurotoxicity in the 6-hydroxydopamine rat model for Parkinson' s disease[ J ]. Mol Ther, 2006,14 (5) :716.
  • 9Ben-Dor f, hsykson P, Goldenberg D, et al. Lentiviral vectors harboring a dual-gene system allow high and homogeneous transgene expression in selected polyclonal human embryonic stem cells[J]. Mol Ther, 2006. 14(2), 255.
  • 10Chan SR, Blackburn EH, Telomeres and telomerase [B]. Philos Trans R Soc Lond B Biol Sci 2004, 359:109 121.

共引文献10

同被引文献21

  • 1Tullio AN, Accili D, Ferrans VJ, et al. Nonmuscle myosin Ⅱ-B is required for normal development of the mouse heart[J]. Proc Natl Acad Sci USA, 1997, 94(23):12407-12412.
  • 2Antony-Debre I, Bluteau D, Itzykson R, et al. MYH10 protein expression in platelets as a biomarker of RUNX1 and FLI1 alterations[J]. Blood, 2012, 120(13):2719-2722.
  • 3Ma X, Bao J, Adelstein RS. Loss of cell adhesion causes hydrocephalus in nonmuscle myosin Ⅱ-B-ablated and mutated mice[J]. Molecular Biology of the Cell, 2007, 18(6):2305-2312.
  • 4Lordier L, Bluteau D, Jalil A, et al. RUNX1-induced silencing of non-muscle myosin heavy chain ⅡB contributes to megakaryocyte polyploidization[J]. Nature Communications, 2012, 3(717):1-10.
  • 5Miyake Y, Inoue N, Nishimura K, et al. Actomyosin tension is required for correct recruitment of adherens junction components and zonula occludens formation[J]. Experimental Cell Research, 2006, 312(9):1637-1650.
  • 6Jacobs K, Van gele M, Forsyth R, et al. P-cadherin counteracts myosin Ⅱ-B function:implications in melanoma progression[J]. Molecular Cancer, 2010, 9(255):1-12.
  • 7Wu Q, Sahasrabudhe RM, Luo LZ, et al. Deficiency in myosin light-chain phosphorylation causes cytokinesis failure and multipolarity in cancer cells[J]. Oncogene, 2010, 29(29):4183-4193.
  • 8Even-Faitelson L, Rosenberg M, Ravid S. PAK1 regulates myosin Ⅱ-B phosphorylation, filament assembly, localization and cell chemotaxis[J]. Cellular Signalling, 2005, 17(9):1137-1148.
  • 9Ma X, Jana SS, Conti MA, et al. Ablation of nonmuscle myosin Ⅱ-B and Ⅱ-C reveals a role for nonmuscle myosin Ⅱ in cardiac myocyte karyokinesis[J]. Molecular Biology of the Cell, 2010, 21(22):3952-3962.
  • 10Betapudi V, Licate LS, Egelhoff TT. Distinct roles of nonmuscle myosin Ⅱ isoforms in the regulation of MDA-MB-231 breast cancer cell spreading and migration[J]. Cancer Research, 2006, 66(9):4725-4733.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部